ERK1 loss accelerates the progression of osteoarthritis in aged mice via NRF2/BACH1 signaling.

Jian Chen, Zhijun Chen, Putao Yuan, Hai Huang, Jiying Wang, Peihua Shi, Xuewu Sun

Biochemical and biophysical research communications 2022 Sep 24

filter terms:

Osteoarthritis (OA) is now a common degenerative joint related disease. However, the clinical efficacy of drugs associated with cartilage regeneration remains limited. In our study, we firstly explored the role of ERK1 in the progression of OA. We clarified that ERK1-deficient mice were susceptible to age-related OA. The higher OARSI scores and more severe cartilage degeneration was observed in the ERK1-deficient mice. ERK1 deficiency decreased the nuclear transportation of Nrf2 in the chondrocytes and accelerated chondrocyte aging in vitro. Moreover, chondrocytes with ERK1 deficiency elevated the nuclear expression of BACH1, resulting in lowered expression of antioxidant enzymes in ERK1-deficient chondrocytes. The Nrf2 activator dimethyl fumarate (DMF) was used. Our experiments demonstrated the protective function of DMF against OA in ERK1 knockout mice. Above all, we confirmed the effects of ERK1 on the progression of OA and clarified the mechanisms underlying these effects. DMF might has significant use in the development of novel drugs for the therapy of OA in the future. Copyright © 2022 Elsevier Inc. All rights reserved.

Citation

Jian Chen, Zhijun Chen, Putao Yuan, Hai Huang, Jiying Wang, Peihua Shi, Xuewu Sun. ERK1 loss accelerates the progression of osteoarthritis in aged mice via NRF2/BACH1 signaling. Biochemical and biophysical research communications. 2022 Sep 24;622:129-135